# Peijia Medical Technology (Suzhou) Co., Ltd.

Organization · id `cardio:org-peijia-medical-technology-suzhou-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Peijia+Medical+Technology+%28Suzhou%29+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Peijia Medical Technology (Suzhou) Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis (`cardio:ct-nct04815785`)
- Sponsors: Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China (`cardio:ct-nct05610566`)
- Sponsors: Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation (`cardio:ct-nct05655897`)
- Sponsors: Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) (`cardio:ct-nct06101888`)
- Sponsors: Target Value Study to Evaluate the Safety and Efficacy of the Taurus NXT® Transcatheter Aortic Valve System for the Treatment of Severe Calcific Aortic Stenosis (`cardio:ct-nct07908225`)

## Provenance

Content hash: 4e60a731080ee4bf95c743cd7d7c9cf7e229a6f87dc5b27ad7980eb2b17a875e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
